Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katherine E. Miller
Observed name:
Miller, Katherine E.
Institutions:
Nationwide Children's Hospital,
The Ohio State University
Observed institutions:
Seattle Children's Hospital,
Nationwide Children's Hospital,
Abigail Wexner Research Institute,
The Ohio State University
ORCID:
0000-0002-3336-7154
Observed ORCID:
0000-0002-3336-7154
OpenAlex ID:
A5103101145
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously
2024
·
Wen Luo
, Hai Hoang
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
12
PDF
Defining the transcriptome of PIK3CA-altered cells in a human capillary malformation using single cell long-read sequencing
2024
·
Michelle A. Wedemeyer
, Tianli Ding
, et al.
·
Scientific Reports
·
11
PDF
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined
2024
·
Margaret Shatara
, Kathleen M. Schieffer
, et al.
·
Frontiers in Oncology
·
5
PDF
Somatic variants activating the RAS-MAPK pathway confer susceptibility to hippocampal sclerosis in drug-resistant epilepsy
2026
·
Lauren Mashburn-Warren
, Ashton Holub
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Intertrochanteric Osteotomies in Children and Adolescents: Principles of Proximal Femoral Deformity Correction
2022
·
Katherine E. Miller
, Vincent S. Mosca
, et al.
·
Journal of the American Academy of Orthopaedic Surgeons
·
4
Single Nuclei Sequencing Reveals Intratumoral Cellular Heterogeneity and Replication Stress in Adrenocortical Carcinoma
2024
·
Liudmila V. Popova
, Elizabeth A. R. Garfinkle
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
Supplementary Table from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Supplementary Figure from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Supplementary Figure from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
PDF
Supplementary Table from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Data from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Supplementary Table from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Supplementary Table from Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis
2023
·
Maximilian O. Schaettler
, Megan M. Richters
, et al.
Supplementary Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
PDF
Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Supplementary Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
PDF
Supplementary Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
2023
·
Katherine E. Miller
, Kevin A. Cassady
, et al.
Show more works
View as search
Works count:
43
Citation count:
39
H-index:
4
I10-index:
2
Year
Topic
Type